Medication Adherence and Its Influencing Factors Among Inflammatory Bowel Disease Patients in China

Int J Gen Med. 2022 Apr 18:15:4141-4149. doi: 10.2147/IJGM.S359082. eCollection 2022.

Abstract

Purpose: To investigate the current state of medication adherence among patients with inflammatory bowel disease (IBD) in China and analyze the influencing factors.

Patients and methods: We recruited as many eligible subjects as possible and a total of 105 patients with IBD finished this cross-sectional survey. The General Information Questionnaire and Morisky Medication Adherence Scale were used as measurement instruments. The factors influencing the Morisky score were studied by multiple linear regression analysis.

Results: The average Morisky score was 6.11 ± 1.93. Univariate analysis showed that there were statistically significant differences in Morisky scores among patients with different ages, education levels, disease types, medication administration methods, medication frequencies, disease understanding and knowledge learning frequencies (P < 0.05). Multiple stepwise linear regression analyses showed that medication frequency, medication administration method and disease understanding were important factors influencing the Morisky score (P < 0.001).

Conclusion: Our data confirmed that the medication adherence of IBD patients was poor, especially among patients taking oral medication, those taking medications with a high frequency and those with a low understanding of the disease. To reduce symptom recurrence and control the disease, medical staff should pay attention to the individual patient factors, simplify the medication regimens, formulate effective coping strategies for drug management support.

Keywords: Crohn’s disease; inflammatory bowel disease; medication adherence; ulcerative colitis.

Grants and funding

This work was supported by the Social Development Scientific Research Projects of the Science and Technology Bureau of Hangzhou (Grant 20201231Y029).